Skip to content

Pharmacokinetics study of Lovidipine butyrate emulsion for injection in Healthy Chinese Volunteers

Pharmacokinetics study of Lovidipine butyrate emulsion for injection in Healthy Chinese Volunteers

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042280
Enrollment
Unknown
Registered
2021-01-17
Start date
2021-01-18
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Experimental group:Lovidipine butyrate emulsion for injection

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. The body mass index (BMI) (kg / m2 of height) is 19-24; 2. The subjects in the comprehensive physical examination were normal in blood and urine routine examination, liver and kidney function examination and electrocardiogram examination, but HBsAg was negative; 3. After knowing the content of the experiment, the volunteers were willing to participate in the experiment and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who have history of drug and food allergy, allergic disease or allergic constitution; 2. Patients with a history of chronic or organic diseases or heart, liver, kidney and blood system diseases; 3. Subjects who have participated in other drug trials within 2 months before the trial; 4. Subjects who participated in blood donation within 3 months before the experiment; 5. Subjects who have used any drugs (including traditional Chinese Medicine) within 2 weeks; 6. People who often use drugs, drink or smoke; 7. Subjects with poor compliance.

Design outcomes

Primary

MeasureTime frame
plasma drug concentration;

Countries

China

Contacts

Public ContactLuo Zhu

West China Hospital, Sichuan University

luozhu720@163.com+86 28-85423837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026